Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

To evaluate the efficacy and safety of an oxaliplatin, fluorouracil (5-FU), and folinic acid (FA) combination in patients with metastatic or advanced gastric cancer (M/AGC). Of the 54 eligible patients with measurable or assessable M/AGC, 53 received oxaliplatin 100 mg/m(2) and FA 400 mg/m(2) (2-hou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology Jg. 20; H. 23; S. 4543
Hauptverfasser:	Louvet, C, André, T, Tigaud, J M, Gamelin, E, Douillard, J Y, Brunet, R, François, E, Jacob, J H, Levoir, D, Taamma, A, Rougier, P, Cvitkovic, E, de Gramont, A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.12.2002
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - secondary Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Drug Administration Schedule Female Fluorouracil - administration & dosage Humans Leucovorin - administration & dosage Male Middle Aged Organoplatinum Compounds - administration & dosage Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Survival Analysis Treatment Outcome
ISSN:	0732-183X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!